Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 April 2018

The University of the Free State invites all Grade 12 learners and their parents to the UFS Open Days. On the Bloemfontein Campus, the Open Day will be held on 12 May 2018, and on the Qwaqwa Campus, Phuthaditjhaba on 26 May 2018.
 
The programme for both Open Days has been streamlined to allow for more time in the faculties in order to gather the necessary academic information. Therefore, there will not be a collective welcoming programme on either campus; however, the academic programme for the respective faculties can be visited DIRECTLY from 09:00. All exhibitions are open from 09:00 till 15:00.

BLOEMFONTEIN CAMPUS OPEN DAY – 12 MAY 2018:


Programme

1. Academic programme in the respective faculties: There will be two welcoming and information sessions by the Dean of each faculty. 

a. Session 1: 09:00–10:00
b. Session 2: 11:00–12:00
c. The venue for each faculty is:
i. Economic and Management Sciences: EMS Auditorium
ii. Education: New Education Auditorium
iii. Health Sciences: Francois Retief Building
iv. Natural and Agricultural Sciences: Callie Human Centre
v. Law: Equitas Building
vi. The Humanities: Odeion
vii. Theology and Religion: Theology Building, Room 21

2. Administrative services in the H van der Merwe Scholtz Hall: Bring your Grade 11 results and a copy of your ID should you wish to apply for 2019 undergraduate studies during the Open Day.
a. Online and hard-copy applications
b. Admissions 
c. General Enquiries
d. UFS Marketing
e. Centre for Teaching and Learning
f. Financial Aid
g. Tuition Fees
h. Housing and Residence Affairs
i. National Benchmark Tests
j. University Access Programmes
k. KovsieGear merchandise 
l. Library and Information Services

3. Student Life programme in front of the Main Building
a. Kovsie2B Social Media
b. Student Life Colleges and Residence Communities exhibitions
c. Arts and Culture
d. Centre for Universal Access and Disability Support (CUADS)
e. Counselling and Development
f. Gender and Sexual Equity Office
g. KovsieSport
h. Student Media
i. Student Wellness and Social Support

4. Student Associations exhibitions at the Thakaneng Bridge
a. Academic associations
b. Charity-based student associations
c. Cultural-based student associations
d. Political associations
e. Religious associations

MEET AND GREET WITH THE RECTOR AND VICE-CHANCELLOR: 

Professor Francis Petersen, Rector and Vice-Chancellor, invites teachers, principals, and parents to engage with him from 12:00 till 14:00, Bloemfontein Campus. If you would like to make use of this opportunity, RSVP by 9 May 2018 to greylinl@ufs.ac.za or bakkese@ufs.ac.za

 

QWAQWA CAMPUS OPEN DAY – 26 MAY 2018:

1. Academic programme in the respective faculties: There will be two welcoming and information sessions by the Assistant Dean of each faculty. 
a. Session 1: 09:00–10:00
b. Session 2: 11:00–12:00
2. Administrative services in the Rolihlahla Mandela Hall: Bring your Grade 11 results and a copy of your ID should you wish to apply for 2019 undergraduate studies during the Open Day.
3. Student Life programme and Student Associations exhibitions. 

MEET AND GREET WITH THE RECTOR AND VICE-CHANCELLOR: 
Professor Francis Petersen, Rector and Vice-Chancellor, invites teachers, principals, and parents to engage with him from 12:00 till 14:00, Qwaqwa Campus. If you would like to make use of this opportunity, RSVP by 23 May 2018 to greylinl@ufs.ac.za or bakkese@ufs.ac.za

GENERAL
Unfortunately no food parcels will be provided to learners. Open Day programmes will be distributed at all entrances on both campuses.
If you require any further information about the Open Days you can contact 051 401 3384/9028. 

2019 APPLICATIONS ARE NOW OPEN
Keep in mind that there are limited spaces in each programme and to avoid disappointment, you are advised to apply as soon as possible. Application to study at the University of the Free State is free. If you want to apply now, click here

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept